Fig. 1From: Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaSwimmer’s Plot of Time on Treatment for 35 Evaluable Patients. Patient 5 and patient 10 received a single dose of nivolumab. Patient 31 and patient 34 had documented PR after discontinuation of nivolumab due to intoleranceBack to article page